APSR2026-653

Yes
Late-Breaking
Submitted
Oral Presentation
AO07-007
 
 
https://storage.unitedwebnetwork.com/files/1285/1220509-46903-APSR-2026-653_440408.pptx
Format: PPTX Only
 
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
11

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Keigo Kani * Rakuwakai Otowa Hospital Department of Respiratory Medicine Kyoto Japan
Masahiro Shirata - Rakuwakai Otowa Hospital Department of Respiratory Medicine Kyoto Japan
Takahiro Yonemoto - Rakuwakai Otowa Hospital Department of Infectious Diseases Kyoto Japan
Riko Enjo - Rakuwakai Otowa Hospital Department of Respiratory Medicine Kyoto Japan
Nobuyo Tamiya - Rakuwakai Otowa Hospital Department of Respiratory Medicine Kyoto Japan
Michiko Tsuchiya - Rakuwakai Otowa Hospital Department of Respiratory Medicine Kyoto Japan
Yukio Nagasaka - Rakuwakai Otowa Hospital Department of Respiratory Medicine Kyoto Japan
Toru Morikawa - Nara City Hospital Department of General Medicine Nara Japan
Haruki Imura - Rakuwakai Otowa Hospital Department of Infectious Diseases Kyoto Japan
Tsukasa Nakamura - Shimane Prefectural Central Hospital Department of Infectious Diseases Izumo Japan
Takeshi Morimoto - Hyogo Medical University Department of Data Science Nishinomiya Japan
 
 
 
 
Presenting Author Details
Keigo
Kani
iwata-keigo@outlook.jp
+819027014137
Under 30
Japan
Original Research
Factors associated with poor outcomes in older patients hospitalized with pneumonia of different frailty status
Maximum 25 words
Abstract Content
The Clinical Frailty Scale (CFS) predicts outcomes in patients hospitalized with pneumonia. However, it remains unclear whether prognostic factors differ according to frailty status. This sub-analysis of the EVERY study evaluated factors associated with poor outcomes in patients admitted from home with pneumonia, stratified by frailty status.
The EVERY study was a multicenter prospective cohort study conducted at three community hospitals between July 2023 and December 2024. We included patients aged ≥65 years admitted from home with pneumonia. Patients were stratified according to baseline frailty (CFS 1–4 vs 5–9). Poor outcome was defined as in-hospital death or non-home discharge. Factors associated with poor outcome were evaluated using multivariable logistic regression. Variables were selected based on previous literature or clinical relevance. The EVERY study was supported by GlaxoSmithKline Biologicals (Study ID: 220114).
Of 2,048 patients, 1,177 had CFS 1–4 and 871 had CFS 5–9. Patients with CFS 5–9 were older (median 86 vs 77 years) and had lower BMI (20.4 vs 22.3 kg/m²). Poor outcome occurred in 50% of patients with CFS 5–9 compared with 22% of those with CFS 1–4. Stratified by CFS 1-4 and 5-9, adjusted odds ratios (aORs) for age ≥75 years , chronic kidney disease, and living with family were 1.51 (95%CI 1.08-2.12), 2.04 (95%CI 1.25-3.27), and 0.69 (95%CI 0.48-0.99), in the CFS 1–4 group, respectively. In the CFS 5–9 group, aOR for BMI <18.5 kg/m² was 1.60 (95%CI 1.15-2.24). In addition, ambulance use and in-hospital fever were associated with poor outcomes, whereas vaccination status reduced the risk in both groups.
In addition to the baseline frailty, several clinical and social factors had significantly associated with poor outcomes in older patients hospitalized for pneumonia.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Pneumonia, Frailty, Prognostic factors
maximum 3 keywords and no abbreviations, separated by commas
This study was a sub-analysis of the EVERY study, which was supported by GlaxoSmithKline Biologicals. The authors declare no other conflicts of interest.
308